Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Boehringer Ingelheim
Katherine R Tuttle; Sibylle J Hauske; Maria Eugenia Canziani; Maria Luiza Caramori; David Cherney; Lisa Cronin; Hiddo J L Heerspink; Christian Hugo; Masaomi Nangaku; Ricardo Correa Rotter; Arnold Silva; Shimoli V Shah; Zhichao Sun; Dorothea Urbach; Dick de Zeeuw; Peter Rossing; ASi in CKD group